All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for CHILDREN'S HEALTHCARE OF ATLANTA · Pediatric health care system

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Georgia · House · Senate · $50,000.00 income · posted Jul 18, 2026

Official filing document

Bills named in this filing 3

HR 2107
Children’s Hospital GME Support Reauthorization Act of 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbying activity 2

Health Issues

Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally

Budget/Appropriations

Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.